News
Find the latest news about Inaphaea BioLabs here
-
Inaphaea wins contract with US biotech
Inaphaea BioLabs is pleased to confirm the execution of a revenue-bearing contract for the provision of patient derived oncology cell (PDC) based services with a US biotech company. The contract is a…
-
BIO 2024 round-up
From 3 to 6 June 2024, Inaphaea’s Head of Strategic Development, Dr Andrew Carnegie and our Scientific Consultant, Dr Mark Eccleston attended the BIO International Convention in San Diego with our partners…
-
Inaphaea BioLabs: one year on
This month marks one year since Inaphaea BioLabs launched. In this blog, Dr Andrew Carnegie, Head of Strategic Commercial Development at Inaphaea, describes how Inaphaea has grown and developed during its first…
-
Inaphaea news round-up: March 2024
This news round-up covers our updates from March. BioEurope was a key highlight, with our commercial team conducting over 60 meetings and spreading the word about Inaphaea to the wider market. To…
-
Meet the commercial team: Inaphaea BioLabs
Inaphaea prides itself on conducting science that is reproducible, human-relevant, and translatable to ensure efficient progress through discovery and preclinical development. Patient-derived cells (PDCs) are at the heart of Inaphaea’s work and…
-
Patient-derived cells (PDCs): the future of drug discovery
Drug discovery is known for its high attrition rates that lead to significant investments of both cost and time. But the emergence of patient-derived cells (PDCs) is on track to revolutionise this…
-
Inaphaea news round-up: January & February 2024
This news round-up covers our updates and highlights from January and February. It has been a busy start to the year for Inaphaea with events, a new collaboration, and progress in the…
-
Celebrating International Day of Women and Girls in Science
The International Day of Women and Girls in Science is an annual event celebrated on 11 February and promotes the full and equal access and participation of women in Science, Technology, Engineering,…
-
Inaphaea BioLabs 2023: A year in review
2023 saw the launch of Inaphaea and we’re delighted to report that the company is continuing to go from strength to strength. With a strong and dedicated scientific and commercial team, and…
-
Inaphaea news round-up: October 2023
This roundup covers our news, updates, and highlights from October. This month was another busy one for the team, seeing us attend ELRIG Drug Discovery – a flagship event in the drug…